Free Malaysia Today Pharmaniaga exits PN17 status
The pharmaceutical group fell into PN17 status in February 2023 after being weighed down by a RM552.3 million provision for slow-moving Covid-19 vaccine inventories.
The pharmaceutical group fell into PN17 status in February 2023 after being weighed down by a RM552.3 million provision for slow-moving Covid-19 vaccine inventories.